UnknownPhase 3NCT04440670

Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia or Death in Extremely Preterm Neonates

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Guangdong Women and Children Hospital
Principal Investigator
Jie Yang
Guangdong Women and Children Hospital
Intervention
autologous cord blood mononuclear cells(biological)
Enrollment
140 enrolled
Eligibility
All sexes
Timeline
2020 – 2023

Study locations (2)

Collaborators

Foshan Fuxing Chancheng Central Hospital · Foshan Women's and Children's Hospital · Hexian Memorial Affiliated Hospital of Southern Medical University · Heyuan Women and Children Hospital · Dongguan Women and Children Hospital · Guangzhou Huadu Women and Children Hospital · Shunde Women and Children Hospital · Guangdong Cord Blood Bank · Huangdu Distric Women and Children Hospital · Longgang Distric Women and Children Hospital,Shenzhen · BoAi Hospital of Zhongshan · Huizhou first Women and Children Hospital · Huizhou second Women and Children Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04440670 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia →

← Back to all trials